WASHINGTON, Oct. 24 /PRNewswire-FirstCall/ -- NMT Medical, Inc. (Nasdaq: NMTI - News), announced that detailed results from its BEST (BioSTAR® Evaluation STudy) trial were presented today at the Late-Breaking Clinical Trials and "First Report" Investigations session at the 2006 Transcatheter Cardiovascular Therapeutics (TCT) 18th Annual Scientific Symposium. In addition, the BioSTAR® clinical data manuscript received expedited review and was published online at the American Heart Association's website, http://www.circulationaha.org, and will be available in the October 2006 print edition of Circulation.
